Related Experiment Videos

Double cardiomyopathy: coexistent cardiac amyloidosis and hypertrophic obstructive cardiomyopathy

W P Buchanan1, S W Schreiter, F R Kahl

  • 1Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157.

Insights

The rare coexistence of hypertrophic obstructive cardiomyopathy (HOCM) and cardiac amyloidosis presents diagnostic challenges. This combination complicates treatment and underscores the need for advanced diagnostic methods in complex cardiac cases.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) and cardiac amyloidosis are distinct cardiac conditions.
  • The simultaneous occurrence of both HOCM and cardiac amyloidosis in a single patient is exceptionally rare.

Observation:

  • A patient presented with clinical and echocardiographic features suggestive of HOCM.
  • Diagnosis of cardiac amyloidosis was delayed, identified only post-myocardial biopsy which initially failed to confirm HOCM.
  • The patient ultimately succumbed to intractable heart failure.

Findings:

  • Autopsy confirmed the co-existence of HOCM and cardiac amyloidosis.
  • The combination of these two cardiomyopathies poses significant diagnostic and therapeutic difficulties.

Implications:

  • This case highlights the diagnostic complexities arising from rare co-existing cardiac pathologies.
  • Effective management strategies for patients with combined HOCM and cardiac amyloidosis require further investigation.

Related Concept Videos